Pressure Ulcers Treatment Market Analysis & Forecast: 2025-2032

Pressure Ulcers Treatment Market Size and Trends

Global pressure ulcers treatment market is estimated to be valued at USD 5.88 Bn in 2025 and is expected to reach USD 8.97 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6% from 2025 to 2032.

Discover market dynamics shaping the industry: Request sample copy

The market is expected to witness positive growth over the forecast period due  to factors such as increasing prevalence of pressure ulcers globally due to rise in lifestyle diseases and  growing geriatric population. Rising healthcare expenditure and availability of advanced wound care products are also expected to provide growth opportunities for pressure ulcers treatment market during the forecast period. The entry of new players and increasing research and development activities in wound care management are expected to drive the market growth over the next few years.

Increasing prevalence of chronic wounds and ulcers among the global population

Rising prevalence of chronic wounds and pressure ulcers globally can drive the pressure ulcers treatment market growth. Patients with chronic conditions like diabetes, obesity, and peripheral arterial disease, that limit mobility, are prone to developing pressure ulcers. Prolonged immobility further increases this risk among bedridden and wheelchair-bound patients, as well as those undergoing long surgical procedures or confined in ICUs. Increasing prevalence of chronic wounds and ulcers among the global population is expected to drive the global negative pressure wound therapy (NPWT) devices market in the near future.

For instance,  on October 5, 2020, according to an article published by National Library of Medicine, titled "The Incidence of Pressure Ulcers and its Associations in Different Wards of the Hospital: A Systematic Review and Meta-Analysis," approximately 2.5 million hospitalizations occur annually in the U.S. due to pressure ulcers. Furthermore, in the U.S., the healthcare system expends approximately US$ 11 billion each year on the prevention and treatment of pressure ulcers.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Increased Awareness and Screening

 There has been significantly higher awareness among public as well as medical practitioners about pressure ulcers, their causes, risk factors and available treatment options in the past few years. Various national and international organizations have been actively conducting educational programs, seminars and campaigns to highlight the significance of this otherwise neglected condition. These are emphasizing the need for improved screening of at-risk patients, timely diagnosis and prompt interventions. These initiatives have sensitized both patients and caregivers about signs and symptoms of pressure ulcers. These people now quickly seek medical help if these notice any abnormality in skin condition. Moreover, regulatory bodies in many countries have made it mandatory for healthcare facilities to conduct regular risk assessment of bedridden and immobile patients. Several hospitals and nursing homes now have dedicated staff to screen patients at regular intervals and implement necessary preventive measures. Advanced ulcer risk assessment tools and devices enable early identification of patients prone to developing pressure ulcers. This allows clinicians to plan strategies for prevention and management at initial stages itself. Higher diagnostic rates coupled with proactive approaches have boosted demand for a variety of therapeutic products and services for pressure ulcer treatment.

Key Takeaways from Analyst:

Global pressure ulcers treatment market is expected to witness growth significantly in the near future. Rising geriatric population globally who are more prone to developing pressure ulcers can drive the market growth. Increased risk of pressure ulcers in immobilized and critically-ill patients also drives the market growth. Advancements in wound care dressings, skin substitutes, and other treatment modalities provide more effective treatment options compared to traditional methods. This, along with rising medical expenditure, is expanding market growth opportunities.

North America  dominates due to highly developed healthcare systems and fair reimbursement scenarios. However, Asia Pacific is likely to witness the highest growth led by China and India. This stems from their huge patient pools and rising healthcare adoption. Europe will also present profitable prospects stemming from the presence of key players and awareness programs regarding pressure ulcer prevention and treatment.

High costs associated with advanced treatments can hamper the market growth. Limited reimbursements in some countries also hamper the market growth. Traditional wound care practices persisting in developing nations can also act as a challenge. Furthermore, lack of screening and late diagnosis in some cases can prove detrimental.

Market Challenges: High cost of advanced wound care products

 High expense associated with advanced wound care products is expected to hamper the global pressure ulcers treatment market growth. For instance, according to the U.S. Department of Health and Human Services, pressure ulcers treatment incur costs ranging from US$ 9.1-11.6 billion annually in the U.S. The expenditure for patient care varies from US$ 20,900 to 151,700 per pressure ulcer. Particularly for individuals residing in rural areas, even the most economical treatment options may be financially unattainable. These considerable costs boosts need for bedsore management equipment.

Market Opportunities: Increasing demand for faster recovery of wounds

Global pressure ulcers treatment market can witness significant growth opportunities due to increasing demand for faster wound recovery. For instance, in March 2021, Smith+Nephew, a medtech company, announced the findings of a real-world study in Spain, demonstrating how a transition to ALLEVYN LIFE Foam Dressings substantially reduced dressing change frequency and weekly costs, while enhancing treatment satisfaction for both clinicians and patients in a community setting. Furthermore, heightened awareness among the public and favorable government initiatives is expected to drive the market growth. For instance, campaigns such as Zero Pressure, Stop the Pressure, and Islandwide Pressure Ulcer Prevention Campaign, spearheaded by the U.K. government, aim to prevent these ulcers through proper management, thus, providing lucrative opportunities for market players.

Discover high revenue pocket segments and roadmap to it: Request sample copy

By Product Type

In terms of product type, wound care dressings segment is estimated to contribute the highest market share of 60.6% in 2025, owing to its effectiveness in treating all wound types. Wound care dressings are vital in treating pressure ulcers, serving as the primary defense against tissue damage and infection. Dressings create a moist environment, speeding up healing, and act as a protective barrier against contaminants. Various types cater to different wound characteristics and patient needs, such as foam for exudate absorption and hydrocolloid for promoting tissue debridement. These are easy to use, causing minimal pain, enhancing treatment adherence, and are suitable for diverse settings including resource-limited areas. Overall, their effectiveness and versatility makes dressings the preferred choice for pressure ulcer management.

By End User

In terms of end user, hospitals segment is estimated to contribute the highest market share of 61.75%, owing to availability of advanced wound care facilities. Hospitals serve as primary healthcare hubs where complex wound cases are typically referred. With advanced infrastructure and skilled personnel, hospitals handle diverse wounds, including pressure ulcers, surgical, diabetic, and vascular. Dedicated wound care teams, including specialists, ensure comprehensive management of ulcers. In-patient units facilitate intensive treatments like dressing changes and debridement. Cutting-edge therapies such as advanced dressings and negative pressure wound therapy are commonly administered in hospitals. The availability of ICUs and trauma units attracts high-risk patients, while outpatient services and follow-ups are preferred due to perceived expertise and safety standards. Insurance coverage further encourages hospital utilization for pressure ulcer treatment, solidifying their position as the primary site for critical wound care.

Regional Insights

Need a Different Region or Segment? Customize now

North America has established itself as the dominant region in the pressure ulcers treatment market with estimated market share of 39.7% in 2025. The market growth can be attributed to factors such as presence of well-developed healthcare infrastructure and higher adoption of advanced wound care products across all healthcare settings in the region. North America have a considerable number of key players that manufacture a wide variety of treatment products. This provides patients and healthcare providers with more options at affordable rates as compared to other regions. Furthermore, growing awareness about importance of early treatment and prevention of pressure ulcers among consumers has also contributed to the leadership position of North America.

Asia Pacific region has emerged as the fastest growing market for pressure ulcers treatment over the past few years. Countries like China, India and Japan have shown highest growth potential owing to rising healthcare expenditure, expansion of private healthcare facilities and increasing focus of international players to tap into these developing markets. Asia Pacific houses nearly 60.5% of the total global population, which translates to a huge patient pool suffering from pressure ulcers. This large patient base seeking affordable treatment options has attracted global medical technology firms to establish local manufacturing plants or sign partnerships with regional distributors. The lack of stringent regulations has allowed easy entry of cost-effective generic products in the market. Rising medical tourism coupled with improving reimbursement schemes can drive the market growth in Asia Pacific.

Market Report Scope

Pressure Ulcers Treatment Industry News

• In March 2021, Smith+Nephew, a medical technology company, unveiled findings from a real-world study conducted in Spain, demonstrating that transitioning to ALLEVYN LIFE Foam Dressings notably decreased dressing change frequency and weekly dressing expenses, alongside enhancing treatment satisfaction for both clinicians and patients in a community environment
• In February 2021, Axis Biosolutions, a deep-science medical technology, obtained European CE mark approval for MAxiCel, an advanced wound care product designed for various chronic wounds, such as pressure ulcers
• In September 2020, Integra LifeSciences Holdings Corp., a medical technology company, finalized a definitive agreement to divest its Extremity Orthopedics business to Smith+Nephew
• In March 2020, Smith+Nephew introduced the PICO 14 Single Use Negative Pressure Wound Therapy System specifically designed for application on high-risk surgical patients
• In February 2020, Integra LifeSciences Holding Corporation unveiled the AmnioExcel Plus Placental Allograft Membrane, its newest wound care solution aimed at bolstering soft tissue repair

*Definition: The pressure ulcers treatment market consists of products and therapies used to heal and prevent pressure ulcers or bed sores. This includes wound care dressings, wound cleaning agents, skin protectants, therapeutic mattresses and cushions, and other support surfaces that help redistribute pressure and increase comfort for patients. The goal of treatments is to promote wound healing and protect vulnerable skin areas that are prone to breakdown and infection if not properly relieved of continuous pressure.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Wound Care Dressings
  • Active Wound Care Therapies
  • Wound Care Devices
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Community Health Centres
  • Homecare Centres
  • Other
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Smith & Nephew PLC
  • Integra LifeSciences Holding Corporation
  • Baxter International Inc. (Hill-Rom Holdings Inc.)
  • Molnlycke Health Care AB
  • Cardinal Health
  • Essity Aktiebolag
  • 3M Company
  • B. Braun Melsungen AG
  • ConvaTec Group PLC
  • Coloplast Group
  • Hill-Rom Holdings, Inc.
  • Medtronic plc
  • Organogenesis Inc.
  • Invacare Corporation
  • Talley Group Ltd
  • Permobil AB
  • GF Health Products, Inc.